WallStSmart

Crowdstrike Holdings Inc (CRWD)vsUipath Inc (PATH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Crowdstrike Holdings Inc generates 199% more annual revenue ($4.81B vs $1.61B). PATH leads profitability with a 17.5% profit margin vs -3.4%. PATH appears more attractively valued with a PEG of 0.42. PATH earns a higher WallStSmart Score of 70/100 (B).

CRWD

Hold

40

out of 100

Grade: D

Growth: 8.0Profit: 2.5Value: 4.0Quality: 4.3
Piotroski: 1/9Altman Z: 1.01

PATH

Strong Buy

70

out of 100

Grade: B

Growth: 8.0Profit: 6.5Value: 10.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CRWD.

PATHUndervalued (+52.0%)

Margin of Safety

+52.0%

Fair Value

$24.34

Current Price

$10.93

$13.41 discount

UndervaluedFair: $24.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRWD2 strengths · Avg: 8.5/10
Market CapQuality
$99.67B9/10

Large-cap with strong market position

Revenue GrowthGrowth
23.3%8/10

Revenue surging 23.3% year-over-year

PATH4 strengths · Avg: 9.5/10
PEG RatioValuation
0.4210/10

Growing faster than its price suggests

EPS GrowthGrowth
107.4%10/10

Earnings expanding 107.4% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Areas to Watch

CRWD4 concerns · Avg: 2.5/10
Operating MarginProfitability
1.0%3/10

Operating margin of 1.0%

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
3.372/10

Expensive relative to growth rate

Price/BookValuation
22.1x2/10

Trading at 22.1x book value

PATH1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
1.392/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CRWD

The strongest argument for CRWD centers on Market Cap, Revenue Growth. Revenue growth of 23.3% demonstrates continued momentum.

Bull Case : PATH

The strongest argument for PATH centers on PEG Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 17.5% and operating margin at 16.6%. Revenue growth of 13.6% demonstrates continued momentum.

Bear Case : CRWD

The primary concerns for CRWD are Operating Margin, Piotroski F-Score, PEG Ratio.

Bear Case : PATH

The primary concerns for PATH are Altman Z-Score.

Key Dynamics to Monitor

CRWD profiles as a growth stock while PATH is a mature play — different risk/reward profiles.

CRWD carries more volatility with a beta of 1.12 — expect wider price swings.

CRWD is growing revenue faster at 23.3% — sustainability is the question.

CRWD generates stronger free cash flow (376M), providing more financial flexibility.

Bottom Line

PATH scores higher overall (70/100 vs 40/100), backed by strong 17.5% margins and 13.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crowdstrike Holdings Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

CrowdStrike Holdings, Inc. provides cloud solutions for endpoint and cloud workload protection in the United States, Australia, Germany, India, Israel, Romania, and the United Kingdom. The company is headquartered in Sunnyvale, California.

Uipath Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

UiPath Inc. provides an end-to-end automation platform offering a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?